3.5 C
New York
Wednesday, February 21, 2024

3 Biotech Bull Cases To Consider In 2024 – And 2 Wildcard Recommendations

3 Biotech Bull Cases To Consider In 2024 – And 2 Wildcard Recommendations


MicroStockHub

Investment Overview

The biotech sector of the stock market is finishing 2023 on a high after what has been a difficult couple of years.

Buoyed by a Big Pharma M&A spree – the globally recognized Pharmas AbbVie (



Source link

Latest stories